Latest filing published 27 Mar 2026 for COMPASS Pathways plc.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Teri Loxam across 2 companies, led by Vaxcyte, Inc. and COMPASS Pathways plc. The record holds 24 filings, for trades running from 1 June 2022 to 26 March 2026.
Every open-market trade on record is a sale: 12 sales worth €1.2M. Outside the open market, there are 10 share grants and 2 option exercises.
The latest filing, published on 27 March 2026, reports a share grant in COMPASS Pathways plc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations